Dr Jinesh Singhavi Shares How Targeted Therapy Helped a Patient Beat Multiple Myeloma

Thane: Multiple myeloma, a blood cancer that accounts for nearly 10% of all hematologic malignancies, is witnessing a major shift in outcomes with the availability of advanced targeted therapies.

Once considered a severe and life-limiting disease, it can now be effectively managed with early diagnosis and personalized treatment, according to Dr Jinesh Singhavi, Consultant – Medical Oncology, KIMS Hospitals, Thane.

Dr Jinesh Singhavi on the Impact of Multiple Myeloma

“Multiple myeloma weakens bones, disrupts normal blood formation, and can severely affect kidneys and immunity if not identified early,” said Dr Jinesh Singhavi. “But with modern therapies, patients have the opportunity to achieve remission and return to active lifestyles.”

Also Read: Jupiter Hospital Thane Successfully Performs High-Risk Liver Tumour Surgery Without Blood Transfusion

The symptoms of multiple myeloma are often subtle, including persistent bone pain, fatigue, fractures, anemia, and repeated infections. Many patients receive a diagnosis only after a fracture or unusual blood test results. Diagnostic investigations typically involve blood and urine tests, bone marrow biopsies, and imaging techniques such as MRI or PET scans.

Case Study Shared by Dr Jinesh Singhavi

Dr Jinesh Singhavi shared the case of a 64-year-old woman who arrived with a fractured femur caused by weakened bones due to multiple myeloma. She had been bedridden for nearly a month and unable to carry out daily activities. Once diagnosed, she was started on a targeted therapy plan tailored to her condition.

Also Read: Vencer Hospital Completes 200 Robotic Joint Replacement Surgeries, Launches Geriatric Wellness Program

“Within a month, she regained the ability to stand. By the second month, she was walking independently. Within six months, she achieved clinical remission,” said Dr Jinesh Singhavi. “Today, she walks over a kilometre daily, continues with oral maintenance therapy, and enjoys an active life.”

Early Diagnosis Is Key, Says Dr Jinesh Singhavi

According to Dr Singhavi, this case demonstrates how multiple myeloma is no longer a terminal condition when treated on time. “With timely diagnosis, targeted drugs, and close monitoring, even elderly patients can regain strength and confidence,” he explained.